Riquibin Neural Tablets

Adult dosage

For adolescents aged 12 years and older and adults, take 1 tablet once a day.

This medication should not be taken by patients with hypercalcemia, patients with sarcoidosis, a systemic inflammatory disease of unknown origin, and patients with kidney diseases. Furthermore, individuals with allergic reactions to any components of this medication, infants under 3 months old, children under 12 months old, patients with kidney stones, and severe renal failure patients should not take this medication. During treatment, this medication should not be taken together with phosphates, calcium salts, oral tetracycline antibiotics, antacids, and drugs like levodopa. Women undergoing medical treatment, those who are pregnant or may become pregnant, breastfeeding women, premature infants, and infants, as well as those with gastrointestinal diseases such as peptic ulcers or chronic colitis, must consult a doctor or pharmacist before using this medication. Individuals with heart or circulatory system disorders, renal impairment, hypoproteinemia, or a history of kidney stones should consult a professional before taking this medication. If nausea, vomiting, diarrhea, loss of appetite, abdominal distension, skin rashes, irregular heartbeats, central nervous system symptoms, hair loss, gastrointestinal disorders, hypotension, pulmonary edema, or similar symptoms occur during use, discontinue use immediately and consult a professional. Additionally, prolonged high-dose use of pyridoxine found in this drug may lead to neurological symptoms, and excessive intake of vitamin B12 may also cause blood anomalies. High doses can exacerbate peptic ulcers or lead to disturbances in glucose metabolism, hyperuricemia, and liver damage, so caution is required. The prescribed use and dosage must be strictly followed, and this medication may turn urine yellow, which could affect some clinical test results. It is advisable to avoid consuming tannin-containing teas such as green tea and black tea during or before/after taking this medication. This medication should be stored out of reach of children, away from direct sunlight, and in a cool, dry place. Furthermore, to prevent misuse and maintain the quality of the medication, do not transfer to another container.

Serious side effects

Cardiac arrest (heart stoppage)

Mild side effects

Nausea, vomiting, diarrhea, loose stools, loss of appetite, abdominal distension, red spots, dermatitis, body odor, bad breath, hair loss, restlessness, gastrointestinal disturbances, digestive disorders, upper abdominal pain, hypotension, pulmonary edema, sensory neuropathy or neurological symptoms, hematological adverse reactions, exacerbation of peptic ulcers, glucose tolerance impairment, hyperuricemia, liver damage, hypernatremia, congestive heart failure, edema, yellow urine discoloration.

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is advisable to maintain storage temperatures between 1 and 30 degrees Celsius. Proper storage will safely preserve the medication's effectiveness.

Appearance

Yellow film-coated oval tablets

Package unit

30 tablets/bottle, 60 tablets/bottle, 90 tablets/bottle, 120 tablets/box [(60 tablets/bottle×2)], 180 tablets/box [(90 tablets/bottle×2)]